Platinum exposure and cause‐specific mortality among patients with testicular cancer-Reference-Cited by-同舟云学术

Platinum exposure and cause‐specific mortality among patients with testicular cancer

Published:2019-11-15 Issue:3 Volume:126 Page:628-639
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Groot Harmke J.¹^ORCID,Leeuwen Flora E.¹,Lubberts Sjoukje²,Horenblas Simon³,Wit Ronald⁴,Witjes J. Alfred⁵,Groenewegen Gerard⁶,Poortmans Philip M.⁷⁸,Hulshof Maarten C. C. M.⁹,Meijer Otto W. M.¹⁰,Jong Igle J.¹¹,Berg Hetty A.¹²,Smilde Tineke J.¹³,Vanneste Ben G. L.¹⁴,Aarts Maureen J. B.¹⁵,Jóźwiak Katarzyna¹⁶¹⁷,Belt‐Dusebout Alexandra W.¹,Gietema Jourik A.²,Schaapveld Michael¹

Affiliation:

1. Department of Psychosocial Research and Epidemiology Netherlands Cancer Institute Amsterdam the Netherlands

2. Department of Medical Oncology University Medical Center Groningen Groningen the Netherlands

3. Department of Radiation Oncology Netherlands Cancer Institute Amsterdam the Netherlands

4. Department of Medical Oncology Erasmus Medical Center Cancer Institute Rotterdam the Netherlands

5. Department of Urology Radboud University Medical Center Nijmegen the Netherlands

6. Department of Medical Oncology, Cancer Center University Medical Center Utrecht Utrecht the Netherlands

7. Department of Radiation Oncology Dr. Bernard Verbeeten Institute Tilburg the Netherlands

8. Department of Radiation Oncology Curie Institute Paris France

9. Department of Radiation Oncology Academic Medical Center Amsterdam the Netherlands

10. Department of Radiation Oncology VU University Medical Center Amsterdam Amsterdam the Netherlands

11. Department of Urology University Medical Center Groningen, University of Groningen Groningen the Netherlands

12. Department of Radiotherapy Catharina Hospital Eindhoven the Netherlands

13. Department of Medical Oncology Jeroen Bosch Hospital 's‐Hertogenbosch the Netherlands

14. Department of Radiotherapy Maastro Clinic Maastricht the Netherlands

15. Department of Medical Oncology Maastricht University Medical Center Maastricht the Netherlands

16. Department of Biostatistics Netherlands Cancer Institute Amsterdam the Netherlands

17. Institute of Biostatistics and Registry Research, Brandenburg Medical School–Theodor Fontane Neuruppin Germany

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32538

Reference42 articles.

1. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality

2. Testicular cancer: Trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970

3. Second malignancies among survivors of germ-cell testicular cancer: A pooled analysis between 13 cancer registries

4. Mortality and incidence of second cancers following treatment for testicular cancer

5. Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testicular cancer in 2023: Current status and recent progress;CA: A Cancer Journal for Clinicians;2023-11-10

2. Causes of death among patients with testicular cancer during the survivorship;European Journal of Surgical Oncology;2023-11

3. Predictors of Multiple Primary Malignancies: Literature Review;Creative surgery and oncology;2023-10-05

4. Causes of death after testicular cancer diagnosis: a US population-based analysis;BMC Urology;2023-09-02

5. Proton therapy for seminoma testis;Tijdschrift voor Urologie;2023-08-25